Matthew Todd speaks to Hannah Coaker, Commissioning Editor
Matthew Todd obtained his PhD in organic chemistry from Cambridge University (UK) in 1999; was a Wellcome Trust postdoc at The University of California, Berkeley (CA, USA); a college fellow back at Cambridge University; a lecturer at Queen Mary, University of London; and since 2005 has been at the School of Chemistry, The University of Sydney, where he is an Associate Professor.
He has a significant interest in open science, and how it may be used to accelerate research, with particular emphasis on open source discovery of new medicines. He founded and currently leads the Open Source Malaria consortium and his open science efforts in the field of schistosomiasis have led to enhancement of the primary drug for this disease, praziquantel. In 2011, he was awarded a NSW Scientist of the Year award in the Emerging Research category for his work in open science and in 2012 the Open Source Malaria consortium was awarded one of three Wellcome Trust/Google/PLoS Accelerating Science Awards.
Disclaimer
The opinions expressed in this interview are those of the interviewee and do not necessarily reflect the views of Future Science Ltd.
Financial & competing interests disclosure
The author has no relevant affiliations or financial involvement with any organization or entity with a financial interest in or financial conflict with the subject matter or materials discussed in the manuscript. This includes employment, consultancies, honoraria, stock ownership or options, expert testimony, grants or patents received or pending, or royalties.
No writing assistance was utilized in the production of this manuscript.